Click to search for your profile
Click to search for condition or expert
Click to open main menu
Share
Share
Share
Click
Share
Share
Condition
Clinical Trials for
Bronchopulmonary Dysplasia
Overview
Find a Doctor
Latest Advances
Clinical Trials
Active Clinical Trials
Search for trials
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
120
Start Date:
May 2021
Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary Dysplasia
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1
Intervention Type:
Drug
Participants:
20
Start Date:
March 1, 2021
Pilot Study of an Inhaled Treatment for Bronchopulmonary Dysplasia
Search for trials
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Biological
Participants:
270
Start Date:
January 2021
A Phase 1b/2, Randomized, Open-Label, Dose-Determined Study Evaluating the Safety, Tolerability, and Efficacy Profile of Intervention With AT-100 (rhSP-D) in Preterm Neonates at High Risk for the Development of Bronchopulmonary Dysplasia (BPD)
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1
Intervention Type:
Biological
Participants:
9
Start Date:
January 2021
Helping Underdeveloped Lungs With Cells (HULC): Mesenchymal Stromal Cells in Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia - Phase 1 Study
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 3
Intervention Type:
Drug
Participants:
1160
Start Date:
December 2020
Randomized Controlled Trial of Budesonide + Surfactant Versus Surfactant Alone in Extremely Preterm Infants (The Budesonide in Babies (BiB) Trial)
Clinical Trial
Status:
Not yet recruiting
Phase:
N/A
Intervention Type:
Procedure
Participants:
906
Start Date:
December 1, 2020
Positive End-Expiratory Pressure (PEEP) Levels During Resuscitation of Preterm Infants at Birth (The POLAR Trial).
Clinical Trial
Status:
Not yet recruiting
Intervention Type:
Device
Participants:
40
Start Date:
December 1, 2020
The Natural Course of Hypercapnia and Its Association With Long-term Respiratory Morbidities in Premature Infants With Chronic Lung Disease
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1
Intervention Type:
Drug
Participants:
54
Start Date:
November 2020
Phase 1 Feasibility Trial of Inhaled Tobramycin in Preterm Infants With Bronchopulmonary Dysplasia
Clinical Trial
Status:
Not yet recruiting
Phase:
N/A
Intervention Type:
Device
Participants:
110
Start Date:
October 31, 2020
The Impact of Lung Recruitment Maneuver in 24-32 Weeks Preterm Babies With Assist-control Volume Guarantee Mode to Their Hemodynamic Status and the Incidence of Bronchopulmonary Dysplasia
Clinical Trial
Status:
Not yet recruiting
Phase:
N/A
Intervention Type:
Dietary Supplement
Participants:
100
Start Date:
October 1, 2020
Vitamin A Oral Supplementation as a Preventive Treatment for Chronic Lung Disease Among Infants Born Before 29 Weeks of Gestation.
Clinical Trial
Status:
Recruiting
Intervention Type:
Other
Participants:
382
Start Date:
September 9, 2020
Long-Term Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely Premature Infants
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1
Intervention Type:
Combination Product
Participants:
30
Start Date:
September 1, 2020
A Prospective Study of Hyperpolarized 129 Xe MRI in in a Pediatric Population With Bronchopulmonary Dysplasia
Showing 1-12 of 88
Next